Key result
Higher PASP linked to ~107% higher mortality risk in heart failure patients.
Why the study?
Less is known about pulmonary hypertension among patients with HF, particularly regarding its prognostic value in the community.
Does higher pulmonary artery systolic pressure (PASP) assessed by Doppler echocardiography predict increased risk of death in community patients with heart failure?
Cohort (n=1,049)
No
Does higher pulmonary artery systolic pressure (PASP) assessed by Doppler echocardiography predict increased risk of death in community patients with heart failure?
In a broad community cohort of heart failure patients, pulmonary hypertension assessed by Doppler echocardiography is highly prevalent and serves as a strong, independent predictor of all-cause and cardiovascular mortality.
PASP by echocardiography may refine mortality risk stratification in community HF; extends prior prognostic data yet leaves open whether it should guide therapy.
Objective To determine among community patients with heart failure (HF), whether pulmonary artery systolic pressure (PASP) assessed by Doppler echocardiography was associated with death and improved risk prediction over established factors, using the integrated discrimination improvement (IDI) and net reclassification improvement (NRI). Background While several studies have focused on idiopathic pulmonary arterial hypertension, less is known about pulmonary hypertension among patients with HF, particularly on its prognostic value in the community. Methods Olmsted County residents with HF between 2003 and 2010 prospectively underwent assessment of ejection fraction (EF), diastolic function, and PASP by Doppler echocardiography. Results PASP was recorded in 1049 of 1153 patients (mean age 76±13, 51% women). Median PASP was 48 mmHg (25th-75th percentile, 37.0-58.0). There were 489 deaths after a follow-up of 2.7±1.9 years. There was a strong positive graded association between PASP and mortality. Increasing PASP was associated with an increased risk of death (HR 1.45, 95%CI 1.13-1.85 for tertile 2; HR 2.07, 95%CI 1.62-2.64 for tertile 3, versus tertile 1), independently of age, sex, comorbidities, EF and diastolic function. Adding PASP to models including these clinical characteristics resulted in an increase in the c-statistic from 0.704 to 0.742 (p=0.007), an IDI gain of 4.2% (p<0.001), and an NRI of 14.1% (p=0.002), indicating that PASP improved prediction of death over traditional prognostic factors. All results were similar for CV death. Conclusion Among community patients with HF, PASP strongly predicts death and provides incremental and clinically relevant prognostic information independently of known predictors of outcomes.
No takes yet. Share an insight, caveat, or question.
Bursi et al. (2012) conducted a cohort in Heart failure (n=1,049). Pulmonary artery systolic pressure (PASP) vs. Lowest PASP tertile (<41 mmHg) was evaluated on All-cause mortality (HR 2.07, 95% CI 1.62-2.64, p=<0.001). Higher pulmonary artery systolic pressure was independently associated with an increased risk of death in heart failure patients, with the highest tertile having over twice the risk (HR 2.07).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: